medicallessons.net
Regorafenib, an Experimental Pill Tested in Colon and Rectal Cancer Patients, on Conference Agenda
Tomorrow the American Society of Clinical Oncology* will host its 9th annual GI Cancers Symposium. Bloomberg and the LA Times have already reported findings of a paper, still in abstract form, to be presented on Saturday. The drug of interest is regorafenib, a pill that loosely inhibits quite a few kinases – enzymes critical in…